HDAC 2/3 inhibitors (Cancer Research UK)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameHDAC 2/3 inhibitors (Cancer Research UK)
Drug Alias NameHDAC inhibitors (Cancer Research UK)histone deacetylase 2/3 inhibitors (Cancer Research UK)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone deacetylase 2 inhibitorsHistone deacetylase 3 inhibitors
TargetsHistone deacetylase 2Histone deacetylase 3
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCancer Research UK
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCancer Research TechnologyCancer Research UK
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A